drugset / Trial / NCT04776486

Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance

NCT04776486

NaSingle-groupOpen-labelDiagnostic

Summary

Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance

Timeline

Start
2020-09-03
Primary completion
2026-01-29
Completion
2026-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Iohexol Diagnostic / imaging agent 5 ml Intravenous

Indications

No indication recorded.